Propel testing excellence with Mayo Clinic quality
Mayo Clinic Laboratories is a one-stop laboratory solution, offering commercial laboratories a vast testing menu, unparalleled customer service, and optimized processes. We work collaboratively with partners to assess their needs, providing the testing they need to expand into new areas and meet their business goals.
As the reference lab for Mayo Clinic, we’ve developed robust logistics and testing protocols applied uniformly for all specimens received, no matter their geographic origin. Whether you send us one test order or thousands, each sample receives the same treatment and level of care, ensuring superior results that help our partners better serve their clients.
“Our clients want personal experiences. They want someone to answer the phone. They want someone to provide answers when they're looking for results of a sample sent a couple days ago. and we deliver those answers.”
Angie Reese-Davis, director of operations, logistics, and specimen services, Mayo Clinic Laboratories
Our difference
News and updates
The latest
Mayo Clinic Laboratories is transforming diagnostics with innovations in 2025 that turned research into real-world solutions for better patient care.
Jane Hermansen, manager of outreach and network development at Mayo Clinic Laboratories, shares with MedicalLab Management magazine how to align the outreach laboratory for growth and rise above the challenges facing the health care industry.
Topic highlights include: Mayo Clinic doctor says Mark Cuban’s Cost Plus Drugs is bringing “access” to U.S. healthcare, New health clinic model is signing up members in Rochester, Pediatric health groups call for national emergency to fight respiratory illnesses
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Lynn Cornell, M.D., to discuss her background in lifelong learning.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Pritt and Dr. Morice discuss common challenges facing many hospital and laboratory leaders today, the important role of lab leaders in advancing patient care, and what to watch in Washington, D.C., as we head into the year’s end.
Michael Baisch has been a systems engineer in the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic for 18 years. Michael partners with the laboratories and business offices to evaluate their workflows for optimal quality, efficiency, and cost. He strives to improve processes so the entire team can get results into the hands of the patient and their care team in an accurate, timely, and cost-effective manner.
Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ malabsorption panel can provide timelier diagnosis for children with chronic diarrhea or unexplained weight loss. The novel panel, which bundles four existing tests, requires just one stool sample.
This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors
Join Mayo Clinic Laboratories at the NSGC Annual Conference in November. Our interactive booth will be staffed by genetic counselors who can discuss and answer questions about our genetic testing.
Topic highlights include: Health care officials prepare as RSV, influenza cases increase in Minnesota, Health and science are on the ballot this election. Here’s what we’re watching, Proposition 209: Arizona voters back lowering maximum interest rates on medical debt
William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Pritt and Dr. Morice discuss their new roles at Mayo Clinic and update listeners on the latest legislative news impacting the laboratory and diagnostic industries. They also highlight the launch of MayoComplete, Mayo Clinic Laboratories’ robust suite of oncology and hematology testing that uses next-generation sequencing to identify and evaluate presence of mutations.
As Tropical Storm Nicole approaches Florida, the Mayo Clinic Laboratories Florida location will close tonight, Nov. 9, at 7:30 p.m. ET, as a safety precaution. The location will remain closed through 7:30 p.m. ET tomorrow, Nov. 10.
Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass spectrometry testing.